Literature DB >> 8392706

Self-stabilized antisense oligodeoxynucleotide phosphorothioates: properties and anti-HIV activity.

J Y Tang1, J Temsamani, S Agrawal.   

Abstract

A new class of oligodeoxyribonucleotides has been designed, referred to here as 'self-stabilized' oligonucleotides. These oligonucleotides have hairpin loop structures at their 3' ends, and show increased resistance to degradation by snake venom phosphodiesterase, DNA polymerase I and fetal bovine serum. The self-stabilized region of the oligonucleotide does not interfere in hybridization with complementary nucleic acids as shown by melting temperature, mobility-shift and RNase H cleavage studies. Various self-stabilized oligonucleotides containing increasingly stable hairpin loop regions were studied for their anti-HIV activity. Pharmacokinetic and stability studies in mice showed increased in vivo persistence of self-stabilized oligonucleotides with respect to their linear counterparts.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8392706      PMCID: PMC309610          DOI: 10.1093/nar/21.11.2729

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  21 in total

1.  Modified deoxyoligonucleotides stable to exonuclease degradation in serum.

Authors:  J P Shaw; K Kent; J Bird; J Fishback; B Froehler
Journal:  Nucleic Acids Res       Date:  1991-02-25       Impact factor: 16.971

2.  Detection and differentiation by sandwich enzyme-linked immunosorbent assay of human T-cell lymphotropic virus type III/lymphadenopathy-associated virus- and acquired immunodeficiency syndrome-associated retroviruslike clinical isolates.

Authors:  J R Higgins; N C Pedersen; J R Carlson
Journal:  J Clin Microbiol       Date:  1986-09       Impact factor: 5.948

3.  Inhibition of HIV-LTR gene expression by oligonucleotides targeted to the TAR element.

Authors:  T Vickers; B F Baker; P D Cook; M Zounes; R W Buckheit; J Germany; D J Ecker
Journal:  Nucleic Acids Res       Date:  1991-06-25       Impact factor: 16.971

4.  Regulation of viral expression of human immunodeficiency virus in vitro by an antisense phosphorothioate oligodeoxynucleotide against rev (art/trs) in chronically infected cells.

Authors:  M Matsukura; G Zon; K Shinozuka; M Robert-Guroff; T Shimada; C A Stein; H Mitsuya; F Wong-Staal; J S Cohen; S Broder
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

5.  Inhibition of herpes simplex virus type 2 growth by phosphorothioate oligodeoxynucleotides.

Authors:  W Y Gao; R N Hanes; M A Vazquez-Padua; C A Stein; J S Cohen; Y C Cheng
Journal:  Antimicrob Agents Chemother       Date:  1990-05       Impact factor: 5.191

6.  Long-term treatment of human immunodeficiency virus-infected cells with antisense oligonucleotide phosphorothioates.

Authors:  J Lisziewicz; D Sun; V Metelev; P Zamecnik; R C Gallo; S Agrawal
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

7.  Synthesis of phosphorothioate analogues of oligodeoxyribonucleotides and their antiviral activity against human immunodeficiency virus (HIV).

Authors:  M Matsukura; G Zon; K Shinozuka; C A Stein; H Mitsuya; J S Cohen; S Broder
Journal:  Gene       Date:  1988-12-10       Impact factor: 3.688

8.  Inhibition of influenza virus replication by phosphorothioate oligodeoxynucleotides.

Authors:  J M Leiter; S Agrawal; P Palese; P C Zamecnik
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

9.  Oligodeoxynucleoside phosphoramidates and phosphorothioates as inhibitors of human immunodeficiency virus.

Authors:  S Agrawal; J Goodchild; M P Civeira; A H Thornton; P S Sarin; P C Zamecnik
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

10.  Inhibition of human immunodeficiency virus in early infected and chronically infected cells by antisense oligodeoxynucleotides and their phosphorothioate analogues.

Authors:  S Agrawal; T Ikeuchi; D Sun; P S Sarin; A Konopka; J Maizel; P C Zamecnik
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

View more
  19 in total

Review 1.  Antiviral therapy for human immunodeficiency virus infections.

Authors:  E De Clercq
Journal:  Clin Microbiol Rev       Date:  1995-04       Impact factor: 26.132

Review 2.  Antigene, ribozyme and aptamer nucleic acid drugs: progress and prospects.

Authors:  R A Stull; F C Szoka
Journal:  Pharm Res       Date:  1995-04       Impact factor: 4.200

3.  Kinetics of conformational fluctuations in DNA hairpin-loops.

Authors:  G Bonnet; O Krichevsky; A Libchaber
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-21       Impact factor: 11.205

4.  Bioactive and nuclease-resistant L-DNA ligand of vasopressin.

Authors:  K P Williams; X H Liu; T N Schumacher; H Y Lin; D A Ausiello; P S Kim; D P Bartel
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

5.  Opening of the extraordinarily stable mini-hairpin d(GCGAAGC).

Authors:  B Jollès; M Réfrégiers; A Laigle
Journal:  Nucleic Acids Res       Date:  1997-11-15       Impact factor: 16.971

6.  Oligonucleotides tethered to a short polyguanylic acid stretch are targeted to macrophages: enhanced antiviral activity of a vesicular stomatitis virus-specific antisense oligonucleotide.

Authors:  V Prasad; S Hashim; A Mukhopadhyay; S K Basu; R P Roy
Journal:  Antimicrob Agents Chemother       Date:  1999-11       Impact factor: 5.191

7.  Most compact hairpin-turn structure exerted by a short DNA fragment, d(GCGAAGC) in solution: an extraordinarily stable structure resistant to nucleases and heat.

Authors:  I Hirao; G Kawai; S Yoshizawa; Y Nishimura; Y Ishido; K Watanabe; K Miura
Journal:  Nucleic Acids Res       Date:  1994-02-25       Impact factor: 16.971

8.  A direct comparison of anti-microRNA oligonucleotide potency.

Authors:  Kim A Lennox; Mark A Behlke
Journal:  Pharm Res       Date:  2010-04-28       Impact factor: 4.200

9.  Nuclease resistance of an extraordinarily thermostable mini-hairpin DNA fragment, d(GCGAAGC) and its application to in vitro protein synthesis.

Authors:  S Yoshizawa; T Ueda; Y Ishido; K Miura; K Watanabe; I Hirao
Journal:  Nucleic Acids Res       Date:  1994-06-25       Impact factor: 16.971

10.  Characterization of fully 2'-modified oligoribonucleotide hetero- and homoduplex hybridization and nuclease sensitivity.

Authors:  L L Cummins; S R Owens; L M Risen; E A Lesnik; S M Freier; D McGee; C J Guinosso; P D Cook
Journal:  Nucleic Acids Res       Date:  1995-06-11       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.